☰

Grant A. Bledsoe, Ph.D. - Publications

Affiliations: 
2004 Medical University of South Carolina, Charleston, SC, United States 
Area:
Biochemistry
Tree Info Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Guo Y, Li P, Gao L, Zhang J, Yang Z, Bledsoe G, Chang E, Chao L, Chao J. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell. PMID 28544111 DOI: 10.1111/Acel.12615  0.591
2016 Chao J, Bledsoe G, Chao L. Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension. PMID 27432868 DOI: 10.1161/Hypertensionaha.116.07861  0.677
2016 Li P, Guo Y, Bledsoe G, Yang Z, Chao L, Chao J. Kallistatin Induces Breast Cancer Cell Apoptosis and Autophagy by Modulating Wnt Signaling and microRNA Synthesis. Experimental Cell Research. PMID 26790955 DOI: 10.1016/J.Yexcr.2016.01.004  0.559
2015 Guo Y, Li P, Bledsoe G, Yang ZR, Chao L, Chao J. Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression. Experimental Cell Research. 337: 103-10. PMID 26156753 DOI: 10.1016/J.Yexcr.2015.06.021  0.608
2015 Li P, Guo Y, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J. Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis. Critical Care (London, England). 19: 200. PMID 25930108 DOI: 10.1186/S13054-015-0919-4  0.555
2014 Chao J, Bledsoe G, Chao L. Kallikrein-kinin in stem cell therapy. World Journal of Stem Cells. 6: 448-57. PMID 25258666 DOI: 10.4252/Wjsc.V6.I4.448  0.63
2014 Gao L, Li P, Zhang J, Hagiwara M, Shen B, Bledsoe G, Chang E, Chao L, Chao J. Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells. Journal of the American Heart Association. 3: e001194. PMID 25237049 DOI: 10.1161/Jaha.114.001194  0.589
2014 Chao J, Bledsoe G, Chao L. Tissue kallikrein-kinin therapy in hypertension and organ damage. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrã¨S Des Recherches Pharmaceutiques. 69: 37-57. PMID 25130039 DOI: 10.1007/978-3-319-06683-7_3  0.653
2014 Li P, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J. Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis. Immunology. 142: 216-26. PMID 24467264 DOI: 10.1111/Imm.12242  0.662
2013 Gao L, Bledsoe G, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarction. Circulation Journal : Official Journal of the Japanese Circulation Society. 77: 2134-44. PMID 23697984 DOI: 10.1253/Circj.Cj-12-1585  0.542
2013 Zhang J, Yang Z, Li P, Bledsoe G, Chao L, Chao J. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6. Molecular and Cellular Biochemistry. 379: 295-301. PMID 23666756 DOI: 10.1007/S11010-013-1654-2  0.567
2012 Liu Y, Bledsoe G, Hagiwara M, Shen B, Chao L, Chao J. Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling. American Journal of Physiology. Renal Physiology. 303: F1230-8. PMID 22811485 DOI: 10.1152/Ajprenal.00257.2012  0.696
2010 Shen B, Gao L, Hsu YT, Bledsoe G, Hagiwara M, Chao L, Chao J. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling. American Journal of Physiology. Heart and Circulatory Physiology. 299: H1419-27. PMID 20729399 DOI: 10.1152/Ajpheart.00591.2010  0.664
2010 Chao J, Shen B, Gao L, Xia CF, Bledsoe G, Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biological Chemistry. 391: 345-55. PMID 20180644 DOI: 10.1515/Bc.2010.042  0.605
2010 Liu Y, Bledsoe G, Hagiwara M, Yang ZR, Shen B, Chao L, Chao J. Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation. American Journal of Physiology. Renal Physiology. 298: F1033-40. PMID 20089675 DOI: 10.1152/Ajprenal.00518.2009  0.694
2009 Smith RS, Gao L, Bledsoe G, Chao L, Chao J. Intermedin is a new angiogenic growth factor. American Journal of Physiology. Heart and Circulatory Physiology. 297: H1040-7. PMID 19592612 DOI: 10.1152/Ajpheart.00404.2009  0.631
2008 Hagiwara M, Bledsoe G, Yang ZR, Smith RS, Chao L, Chao J. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. American Journal of Physiology. Renal Physiology. 295: F1735-43. PMID 18829738 DOI: 10.1152/Ajprenal.90427.2008  0.711
2008 Bledsoe G, Shen B, Yao YY, Hagiwara M, Mizell B, Teuton M, Grass D, Chao L, Chao J. Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury. Toxicological Sciences : An Official Journal of the Society of Toxicology. 102: 433-43. PMID 18227104 DOI: 10.1093/Toxsci/Kfn008  0.7
2007 Chao J, Li HJ, Yao YY, Shen B, Gao L, Bledsoe G, Chao L. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension. 49: 490-7. PMID 17224475 DOI: 10.1161/01.Hyp.0000255925.01707.Eb  0.695
2006 Chao J, Bledsoe G, Yin H, Chao L. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biological Chemistry. 387: 665-75. PMID 16800727 DOI: 10.1515/Bc.2006.085  0.64
2006 Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery. Human Gene Therapy. 17: 545-55. PMID 16716111 DOI: 10.1089/Hum.2006.17.545  0.75
2006 Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, Chao J. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 624-33. PMID 16401625 DOI: 10.1093/Ndt/Gfi225  0.632
2005 Xia CF, Bledsoe G, Chao L, Chao J. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats. American Journal of Physiology. Renal Physiology. 289: F622-31. PMID 15886273 DOI: 10.1152/Ajprenal.00427.2004  0.683
2004 Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney International. 66: 722-32. PMID 15253727 DOI: 10.1111/J.1523-1755.2004.00794.X  0.742
2003 Bledsoe G, Chao L, Chao J. Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology. 285: H1479-88. PMID 12816755 DOI: 10.1152/Ajpheart.01129.2002  0.598
2001 Chen VC, Chao L, Pimenta DC, Bledsoe G, Juliano L, Chao J. Identification of a major heparin-binding site in kallistatin. The Journal of Biological Chemistry. 276: 1276-84. PMID 11016932 DOI: 10.1074/Jbc.M005791200  0.505
Show low-probability matches.